Trials / Completed
CompletedNCT01853696
Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty
Prospective, Randomized Comparison of Corticosteroid Dosing Regimens Following Endothelial Keratoplasty
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 167 (actual)
- Sponsor
- Cornea Research Foundation of America · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Graft rejection has traditionally been one of the leading causes of cornea transplant failure. To help prevent rejection, corticosteroid eye drops are used for an extended period after transplant surgery. The purpose of this study is to compare the efficacy and side effects of different corticosteroid dosing regimens after endothelial keratoplasty (cornea transplant) surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | loteprednol etabonate | |
| DRUG | prednisolone acetate 1% |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2013-05-15
- Last updated
- 2015-05-15
- Results posted
- 2015-04-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01853696. Inclusion in this directory is not an endorsement.